Review
Copyright ©The Author(s) 2015.
World J Gastroenterol. Jul 21, 2015; 21(27): 8271-8283
Published online Jul 21, 2015. doi: 10.3748/wjg.v21.i27.8271
Table 5 Renal cell carcinoma studies n (%)
AuthorType of microsphereType of mets (patients)Response criteriaResponseMedian OS
(publish date and study type)(average dosage or activity)@ 1st assessment
Abdelmaksoud et al[30]SIR-SpheresRCC (6)mRECIST3 CR (60)12 mo
(3/2012, RS)(median 1.89 Gbq)@ 25 mo (mean)1 PR (20)
1 PD (20)
1 lost
Hamoui et al[38]TherasphereRCC (1)Unspecified1 (100) SDPatient died 23 mo after SIRT
(2/2013, case report)(80 Gy)@ 1.8 mo